Serotonin-3 Receptor Antagonist [EPC]

Serotonin-3 Receptor Antagonist [EPC] was reported 135784 times

Drugs of the Serotonin-3 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 APPENDICOLITH 297 0.7674
1 SLEEP DISORDER THERAPY 151 0.7626
2 ANTACID THERAPY 94 0.7231
3 LYMPHOID TISSUE HYPOPLASIA 88 0.5752
4 THYMUS HYPOPLASIA 86 0.4943
5 ANALGESIC THERAPY 153 0.4766
6 DRUG THERAPY 139 0.4100
7 ANTICOAGULANT THERAPY 96 0.3380
8 LEFT-TO-RIGHT CARDIAC SHUNT 93 0.3153
9 NEUROLOGIC NEGLECT SYNDROME 172 0.3094
10 CAROTID ARTERY THROMBOSIS 183 0.2155
11 DISSEMINATED ASPERGILLOSIS 92 0.1949
12 ADJUSTMENT DISORDER 180 0.1385
13 TEMPERATURE REGULATION DISORDER 305 0.1368
14 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 142 0.1337
15 HYPERPHOSPHATAEMIA 243 0.1129
16 APLASTIC ANAEMIA 552 0.1056
17 NEPHROGENIC ANAEMIA 471 0.1016
18 BLOOD PHOSPHORUS INCREASED 261 0.0955
19 HYPERPARATHYROIDISM SECONDARY 229 0.0913
20 FEBRILE NEUTROPENIA 5633 0.0848
21 NEUTROPENIC COLITIS 151 0.0729
22 REBOUND ACID HYPERSECRETION 215 0.0710
23 PLATELET TRANSFUSION 91 0.0707
24 FOETAL DEATH 362 0.0697
25 PERSONALITY DISORDER 178 0.0679
26 INFUSION SITE DISCHARGE 119 0.0678
27 NEUTROPENIC SEPSIS 481 0.0673
28 FOOD ALLERGY 485 0.0628
29 TORSADE DE POINTES 486 0.0619
30 HEART DISEASE CONGENITAL 201 0.0568
31 FEBRILE BONE MARROW APLASIA 241 0.0567
32 APLASIA 109 0.0556
33 SEROTONIN SYNDROME 1068 0.0555
34 VENTRICULAR FIBRILLATION 606 0.0545
35 LONG QT SYNDROME 130 0.0542
36 PSEUDOMONAL SEPSIS 94 0.0536
37 OCULOGYRIC CRISIS 115 0.0535
38 VASCULAR DEVICE INFECTION 241 0.0531
39 TOTAL LUNG CAPACITY DECREASED 83 0.0519
40 END STAGE RENAL DISEASE 944 0.0517
41 CLONUS 137 0.0500
42 HYPOPHOSPHATAEMIA 359 0.0485
43 CYTOKINE RELEASE SYNDROME 958 0.0477
44 MUCOSAL INFLAMMATION 1217 0.0464
45 LARYNGOSPASM 124 0.0461
46 PLEURITIC PAIN 124 0.0449
47 STRIDOR 132 0.0448
48 DEVICE INFUSION ISSUE 108 0.0435
49 LUNG OPACITY 114 0.0432
50 ESCHERICHIA BACTERAEMIA 101 0.0429
51 IRON DEFICIENCY 193 0.0429
52 APPENDICITIS 394 0.0421
53 INFUSION SITE HAEMORRHAGE 137 0.0416
54 ATELECTASIS 395 0.0408
55 BLOOD URIC ACID INCREASED 232 0.0401
56 INFUSION SITE BRUISING 86 0.0398
57 HOSPICE CARE 389 0.0393
58 CANCER PAIN 98 0.0383
59 IMMUNODEFICIENCY 569 0.0381
60 INFUSION SITE PAIN 490 0.0380
61 GANGRENE 225 0.0373
62 INFUSION SITE SWELLING 233 0.0370
63 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 187 0.0369
64 INFUSION SITE ERYTHEMA 311 0.0369
65 INFUSION SITE PRURITUS 116 0.0367
66 TRANSFUSION 385 0.0367
67 INFUSION SITE INFECTION 85 0.0365
68 FAILURE TO THRIVE 189 0.0364
69 ELECTROCARDIOGRAM QT PROLONGED 1288 0.0358
70 CLOSTRIDIUM DIFFICILE COLITIS 378 0.0356
71 MYASTHENIA GRAVIS 280 0.0346
72 SENSORY LOSS 276 0.0343
73 TROPONIN INCREASED 258 0.0339
74 ENTEROCOLITIS 192 0.0332
75 CARDIOGENIC SHOCK 472 0.0329
76 TYPE I HYPERSENSITIVITY 115 0.0326
77 HYPOMAGNESAEMIA 454 0.0326
78 AORTIC STENOSIS 113 0.0324
79 HYPOXIA 1141 0.0324
80 CHRONIC KIDNEY DISEASE 2437 0.0320
81 BLOOD MAGNESIUM DECREASED 276 0.0319
82 RHINOVIRUS INFECTION 121 0.0311
83 RESPIRATORY SYMPTOM 88 0.0309
84 STAPHYLOCOCCAL BACTERAEMIA 133 0.0306
85 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 181 0.0305
86 NON-CARDIAC CHEST PAIN 96 0.0303
87 BACTERAEMIA 358 0.0301
88 ASCITES 883 0.0300
89 PSYCHOLOGICAL TRAUMA 257 0.0297
90 BACTERIAL INFECTION 552 0.0296
91 HYDRONEPHROSIS 220 0.0294
92 NEUTROPHIL COUNT ABNORMAL 83 0.0293
93 CARBOHYDRATE ANTIGEN 125 INCREASED 100 0.0293
94 HYPOKALAEMIA 1351 0.0292
95 PERIPHERAL SENSORY NEUROPATHY 171 0.0292
96 HYPERREFLEXIA 101 0.0290
97 PULSELESS ELECTRICAL ACTIVITY 121 0.0289
98 ENTERITIS 185 0.0289
99 TUMOUR LYSIS SYNDROME 254 0.0288
100 IMPAIRED GASTRIC EMPTYING 393 0.0288
101 VENTRICULAR TACHYCARDIA 475 0.0287
102 ARTERIAL OCCLUSIVE DISEASE 225 0.0286
103 PRODUCT ADMINISTRATION INTERRUPTED 224 0.0285
104 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 94 0.0284
105 SMALL INTESTINAL OBSTRUCTION 346 0.0281
106 NEUTROPHIL COUNT DECREASED 1141 0.0280
107 OTITIS MEDIA 92 0.0278
108 TASTE DISORDER 559 0.0275
109 THROMBOCYTOPENIA 3076 0.0275
110 COELIAC DISEASE 268 0.0273
111 HEMIPLEGIA 226 0.0271
112 ATRIAL SEPTAL DEFECT 226 0.0270
113 HEPATIC CYTOLYSIS 343 0.0269
114 RED CELL DISTRIBUTION WIDTH INCREASED 111 0.0267
115 UPPER RESPIRATORY TRACT INFECTION 1224 0.0265
116 HYPONATRAEMIA 1474 0.0261
117 SINUS TACHYCARDIA 371 0.0261
118 LEFT VENTRICULAR DYSFUNCTION 174 0.0260
119 PULSE ABSENT 123 0.0258
120 HYPOALBUMINAEMIA 199 0.0256
121 PROCTALGIA 164 0.0255
122 HYPERVOLAEMIA 126 0.0255
123 ARTERIOSPASM CORONARY 102 0.0254
124 ACUTE KIDNEY INJURY 3855 0.0252
125 ABDOMINAL TENDERNESS 125 0.0251
126 HYPOVOLAEMIA 147 0.0251
127 VENOOCCLUSIVE LIVER DISEASE 124 0.0251
128 HAIR COLOUR CHANGES 312 0.0250
129 PARONYCHIA 110 0.0250
130 CYTOMEGALOVIRUS VIRAEMIA 111 0.0249
131 PRESCRIBED OVERDOSE 480 0.0248
132 OESOPHAGITIS 270 0.0247
133 MULTIPLE ORGAN DYSFUNCTION SYNDROME 700 0.0247
134 BURSITIS 298 0.0245
135 BREATH SOUNDS ABNORMAL 121 0.0245
136 CONSTIPATION 5319 0.0244
137 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 93 0.0243
138 CONGENITAL ANOMALY 187 0.0241
139 ENCEPHALOPATHY 590 0.0240
140 NEUTROPENIA 3264 0.0240
141 ILEUS 298 0.0240
142 INTESTINAL ISCHAEMIA 132 0.0239
143 NEUROPATHY PERIPHERAL 2278 0.0239
144 PANCYTOPENIA 1338 0.0239
145 SEPSIS 2654 0.0238
146 PATENT DUCTUS ARTERIOSUS 94 0.0237
147 METASTASES TO LYMPH NODES 159 0.0235
148 TACHYPNOEA 320 0.0235
149 MALNUTRITION 263 0.0235
150 RENAL TUBULAR NECROSIS 230 0.0234
151 DERMATITIS ACNEIFORM 142 0.0233
152 LEUKOPENIA 1163 0.0232
153 ORAL CANDIDIASIS 306 0.0232
154 ACUTE RESPIRATORY FAILURE 446 0.0232
155 HYPERBILIRUBINAEMIA 240 0.0231
156 ELECTROLYTE IMBALANCE 269 0.0231
157 MOTOR DYSFUNCTION 235 0.0230
158 COLITIS 874 0.0230
159 CYTOPENIA 281 0.0229
160 SEDATION 600 0.0229
161 PROTEIN TOTAL DECREASED 86 0.0228
162 INFUSION RELATED REACTION 1512 0.0228
163 SINUS CONGESTION 307 0.0227
164 STOMATITIS 1378 0.0227
165 BLOOD PHOSPHORUS DECREASED 83 0.0227
166 FULL BLOOD COUNT DECREASED 457 0.0227
167 FULL BLOOD COUNT ABNORMAL 238 0.0225
168 RED BLOOD CELL COUNT DECREASED 643 0.0225
169 DEHYDRATION 2999 0.0225
170 AFFECT LABILITY 215 0.0223
171 HAIR DISORDER 184 0.0223
172 ANHEDONIA 586 0.0223
173 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 516 0.0221
174 UROSEPSIS 204 0.0221
175 BENIGN PROSTATIC HYPERPLASIA 114 0.0221
176 RASH MACULO-PAPULAR 491 0.0220
177 STRESS CARDIOMYOPATHY 128 0.0220
178 NEURALGIA 534 0.0219
179 ACUTE PULMONARY OEDEMA 123 0.0219
180 PLEURAL EFFUSION 1326 0.0218
181 FLANK PAIN 204 0.0217
182 MUSCLE SPASTICITY 267 0.0217
183 VENTRICULAR SEPTAL DEFECT 124 0.0216
184 SEASONAL ALLERGY 306 0.0216
185 TOXIC ENCEPHALOPATHY 108 0.0213
186 WEIGHT FLUCTUATION 223 0.0213
187 PLATELET COUNT DECREASED 2260 0.0212
188 LARGE INTESTINE PERFORATION 147 0.0211
189 LYMPHOCYTE COUNT DECREASED 374 0.0211
190 EATING DISORDER 449 0.0211
191 SEPTIC SHOCK 917 0.0211
192 WHITE BLOOD CELL COUNT DECREASED 2271 0.0209
193 ORAL PAIN 465 0.0207
194 VOMITING 9746 0.0207
195 BLOOD ALBUMIN DECREASED 164 0.0207
196 STAPHYLOCOCCAL SEPSIS 102 0.0206
197 ANAPHYLACTOID REACTION 85 0.0206
198 TUMOUR MARKER INCREASED 99 0.0206
199 TUBULOINTERSTITIAL NEPHRITIS 386 0.0206
200 HYPERTRANSAMINASAEMIA 143 0.0205
201 GASTROINTESTINAL MOTILITY DISORDER 110 0.0205
202 RENAL INJURY 610 0.0205
203 NAUSEA 16242 0.0205
204 VITAMIN B12 DEFICIENCY 83 0.0205
205 DEVICE RELATED INFECTION 315 0.0204
206 HEMIPARESIS 345 0.0203
207 OXYGEN SATURATION DECREASED 1144 0.0203
208 EMBOLISM 169 0.0203
209 CARDIAC MURMUR 176 0.0203
210 BLOOD CREATINE INCREASED 90 0.0203
211 PNEUMOTHORAX 322 0.0203
212 HYPOPHAGIA 518 0.0202
213 CANDIDA INFECTION 342 0.0202
214 URINE OUTPUT DECREASED 177 0.0202
215 HAEMOGLOBIN INCREASED 92 0.0201
216 LYMPHOPENIA 285 0.0201
217 CLOSTRIDIUM DIFFICILE INFECTION 439 0.0201
218 RESPIRATORY SYNCYTIAL VIRUS INFECTION 175 0.0201
219 NEPHROLITHIASIS 921 0.0201
220 DERMATITIS CONTACT 228 0.0200
221 MYOCLONUS 237 0.0199
222 METASTASES TO LIVER 349 0.0198
223 DECREASED APPETITE 4596 0.0198
224 SUPRAVENTRICULAR TACHYCARDIA 189 0.0197
225 HICCUPS 162 0.0197
226 RETCHING 419 0.0196
227 UNRESPONSIVE TO STIMULI 507 0.0196
228 TRICUSPID VALVE INCOMPETENCE 156 0.0196
229 COLITIS ISCHAEMIC 132 0.0195
230 ANAEMIA 3730 0.0195
231 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 186 0.0195
232 PLASMA CELL MYELOMA 759 0.0194
233 MENTAL STATUS CHANGES 538 0.0194
234 RESPIRATORY TRACT CONGESTION 307 0.0193
235 POLYNEUROPATHY 231 0.0193
236 HYPERNATRAEMIA 96 0.0192
237 ANAPHYLACTIC REACTION 1060 0.0192
238 APPETITE DISORDER 127 0.0191
239 BLOOD CALCIUM INCREASED 168 0.0191
240 TACHYCARDIA 1693 0.0190
241 BODY TEMPERATURE INCREASED 388 0.0190
242 APNOEA 148 0.0190
243 BLOOD POTASSIUM DECREASED 571 0.0190
244 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 103 0.0189
245 ASPIRATION 206 0.0188
246 BLOOD ALKALINE PHOSPHATASE INCREASED 467 0.0188
247 PNEUMONITIS 512 0.0188
248 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 146 0.0188
249 TOXIC EPIDERMAL NECROLYSIS 285 0.0187
250 ODYNOPHAGIA 112 0.0187
251 BRAIN FOG 294 0.0187
252 NEUROTOXICITY 327 0.0186
253 BLOOD LACTIC ACID INCREASED 98 0.0186
254 BLOOD BILIRUBIN INCREASED 502 0.0186
255 BRONCHOSPASM 265 0.0186
256 HYPERCALCAEMIA 229 0.0185
257 HAIR TEXTURE ABNORMAL 248 0.0185
258 IMPAIRED QUALITY OF LIFE 266 0.0185
259 COORDINATION ABNORMAL 258 0.0185
260 SKIN HAEMORRHAGE 274 0.0185
261 PYREXIA 6397 0.0185
262 METASTASES TO CENTRAL NERVOUS SYSTEM 238 0.0184
263 HYPERLIPIDAEMIA 218 0.0182
264 RENAL FAILURE 2421 0.0182
265 SINUS DISORDER 359 0.0181
266 BONE MARROW FAILURE 365 0.0179
267 ANAPHYLACTIC SHOCK 463 0.0179
268 MADAROSIS 208 0.0179
269 DISEASE PROGRESSION 2120 0.0179
270 SINUS BRADYCARDIA 173 0.0179
271 BLOOD SODIUM DECREASED 336 0.0178
272 HAEMORRHOIDS 347 0.0178
273 APHASIA 537 0.0178
274 ABDOMINAL PAIN 4112 0.0177
275 CACHEXIA 90 0.0175
276 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 179 0.0174
277 ANAL INCONTINENCE 156 0.0173
278 BLOOD CALCIUM DECREASED 195 0.0173
279 PATHOLOGICAL FRACTURE 88 0.0173
280 CARDIAC ARREST 1426 0.0173
281 EJECTION FRACTION DECREASED 268 0.0172
282 TRISMUS 89 0.0172
283 LUNG INFILTRATION 152 0.0172
284 SKIN TOXICITY 97 0.0171
285 PRE-EXISTING CONDITION IMPROVED 107 0.0171
286 DYSPNOEA EXERTIONAL 644 0.0171
287 ANAL ABSCESS 92 0.0171
288 HYPOCALCAEMIA 323 0.0170
289 ULCER 271 0.0170
290 HAEMORRHOIDAL HAEMORRHAGE 83 0.0170
291 FAECALOMA 93 0.0170
292 INTESTINAL PERFORATION 190 0.0169
293 BLOOD CREATININE INCREASED 1105 0.0169
294 ATRIAL FLUTTER 135 0.0169
295 BLOOD TEST ABNORMAL 236 0.0168
296 CHOLECYSTITIS 200 0.0168
297 RESPIRATORY DISTRESS 463 0.0168
298 PANCREATITIS ACUTE 377 0.0168
299 CARDIOMEGALY 206 0.0167
300 OROPHARYNGEAL DISCOMFORT 151 0.0167
301 DECUBITUS ULCER 136 0.0167
302 CYANOSIS 262 0.0166
303 HAEMATOCRIT DECREASED 330 0.0166
304 KLEBSIELLA INFECTION 84 0.0166
305 LIPASE INCREASED 127 0.0166
306 NIGHTMARE 573 0.0165
307 EXPOSURE DURING PREGNANCY 1029 0.0165
308 GENERAL PHYSICAL HEALTH DETERIORATION 1901 0.0164
309 HYPERHIDROSIS 2116 0.0164
310 ALANINE AMINOTRANSFERASE INCREASED 1007 0.0164
311 PLATELET COUNT ABNORMAL 99 0.0164
312 ACUTE MYELOID LEUKAEMIA 255 0.0163
313 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 280 0.0163
314 ASPARTATE AMINOTRANSFERASE INCREASED 867 0.0163
315 DIARRHOEA 10529 0.0163
316 HYPOTENSION 3268 0.0163
317 ORTHOSTATIC HYPOTENSION 283 0.0162
318 FLUID RETENTION 817 0.0160
319 HAEMATEMESIS 407 0.0160
320 CYSTITIS 510 0.0160
321 HAEMOGLOBIN ABNORMAL 103 0.0160
322 GASTROENTERITIS 233 0.0160
323 FOETAL GROWTH RESTRICTION 97 0.0159
324 PERIORBITAL SWELLING 90 0.0159
325 PERICARDIAL EFFUSION 368 0.0159
326 LEUKOCYTOSIS 288 0.0159
327 POOR VENOUS ACCESS 164 0.0158
328 GOUT 284 0.0158
329 NEOPLASM PROGRESSION 545 0.0157
330 FEEDING DISORDER 317 0.0156
331 DYSTONIA 303 0.0156
332 VENTRICULAR EXTRASYSTOLES 162 0.0156
333 CELLULITIS 783 0.0155
334 EPISTAXIS 1161 0.0155
335 MOUTH ULCERATION 326 0.0155
336 ESCHERICHIA INFECTION 127 0.0154
337 RASH ERYTHEMATOUS 738 0.0154
338 CONTRAINDICATED PRODUCT ADMINISTERED 466 0.0154
339 HAEMOGLOBIN DECREASED 1578 0.0154
340 PHARYNGITIS 190 0.0153
341 UPPER GASTROINTESTINAL HAEMORRHAGE 257 0.0153
342 DYSARTHRIA 575 0.0153
343 INTESTINAL OBSTRUCTION 575 0.0152
344 MUSCULOSKELETAL CHEST PAIN 236 0.0152
345 HYPERTHERMIA 116 0.0152
346 ACIDOSIS 116 0.0152
347 COVID-19 PNEUMONIA 179 0.0151
348 ORAL DISORDER 111 0.0151
349 ACUTE RESPIRATORY DISTRESS SYNDROME 267 0.0151
350 GASTROENTERITIS VIRAL 272 0.0151
351 PULMONARY EMBOLISM 1429 0.0150
352 MALIGNANT NEOPLASM PROGRESSION 1538 0.0150
353 NEUTROPHIL COUNT INCREASED 153 0.0149
354 FACIAL PAIN 133 0.0149
355 URINARY TRACT INFECTION 2528 0.0148
356 SKIN INFECTION 166 0.0148
357 OSTEOPENIA 224 0.0147
358 HEPATOMEGALY 145 0.0147
359 PULMONARY MASS 219 0.0147
360 CHOLANGITIS 91 0.0147
361 PETECHIAE 153 0.0146
362 BRAIN OEDEMA 185 0.0146
363 FLUID OVERLOAD 213 0.0146
364 PNEUMONIA 4705 0.0145
365 TRANSAMINASES INCREASED 323 0.0145
366 RESPIRATORY FAILURE 1058 0.0145
367 FATIGUE 11269 0.0145
368 PULMONARY HYPERTENSION 301 0.0144
369 LIVER FUNCTION TEST INCREASED 307 0.0143
370 RALES 83 0.0143
371 C-REACTIVE PROTEIN INCREASED 520 0.0143
372 METASTASES TO BONE 234 0.0142
373 VITAMIN D DEFICIENCY 139 0.0142
374 CHILLS 1668 0.0142
375 ADRENAL INSUFFICIENCY 172 0.0142
376 HEREDITARY ANGIOEDEMA 152 0.0142
377 DYSPHAGIA 1343 0.0141
378 INFUSION SITE EXTRAVASATION 88 0.0141
379 DISSEMINATED INTRAVASCULAR COAGULATION 199 0.0141
380 ACUTE CORONARY SYNDROME 117 0.0141
381 IRON DEFICIENCY ANAEMIA 130 0.0141
382 HAEMOLYTIC ANAEMIA 126 0.0140
383 GASTRITIS 370 0.0140
384 CHOLECYSTITIS CHRONIC 94 0.0140
385 CARDIO-RESPIRATORY ARREST 586 0.0140
386 METASTASIS 100 0.0140
387 BLOOD LACTATE DEHYDROGENASE INCREASED 221 0.0139
388 ECONOMIC PROBLEM 211 0.0139
389 LYMPHOEDEMA 96 0.0139
390 CARDIOMYOPATHY 205 0.0139
391 MATERNAL EXPOSURE DURING PREGNANCY 1236 0.0139
392 INSURANCE ISSUE 212 0.0138
393 GASTROOESOPHAGEAL REFLUX DISEASE 1116 0.0138
394 ABDOMINAL DISTENSION 1447 0.0138
395 NEPHROPATHY TOXIC 155 0.0138
396 ONYCHOCLASIS 95 0.0138
397 HAEMOPTYSIS 385 0.0138
398 CARDIOTOXICITY 123 0.0138
399 RESPIRATORY TRACT INFECTION 359 0.0138
400 AGRANULOCYTOSIS 256 0.0138
401 RHINITIS 111 0.0138
402 DECREASED IMMUNE RESPONSIVENESS 135 0.0137
403 PREMATURE DELIVERY 219 0.0137
404 PRODUCTIVE COUGH 655 0.0137
405 GASTROINTESTINAL DISORDER 1229 0.0137
406 PAIN IN JAW 388 0.0137
407 METASTASES TO LUNG 157 0.0136
408 POST-TRAUMATIC STRESS DISORDER 91 0.0136
409 GENERALISED OEDEMA 168 0.0136
410 TOXIC SKIN ERUPTION 136 0.0135
411 GAMMA-GLUTAMYLTRANSFERASE INCREASED 299 0.0135
412 SNEEZING 302 0.0135
413 CIRCULATORY COLLAPSE 229 0.0134
414 RIGHT VENTRICULAR FAILURE 94 0.0134
415 PSEUDOMONAS INFECTION 115 0.0134
416 PRODUCT DISTRIBUTION ISSUE 124 0.0134
417 ASTHENIA 5023 0.0133
418 LOW BIRTH WEIGHT BABY 106 0.0133
419 HEPATIC ENZYME INCREASED 905 0.0133
420 BLOOD UREA INCREASED 222 0.0132
421 MITRAL VALVE INCOMPETENCE 150 0.0132
422 BACK PAIN 3072 0.0132
423 GASTROINTESTINAL INFECTION 118 0.0132
424 BRONCHOPULMONARY ASPERGILLOSIS 102 0.0131
425 CHEST DISCOMFORT 1341 0.0131
426 SKIN LACERATION 142 0.0130
427 HEPATOCELLULAR INJURY 185 0.0130
428 SECOND PRIMARY MALIGNANCY 108 0.0130
429 WEIGHT DECREASED 3622 0.0130
430 BONE PAIN 760 0.0130
431 EAR INFECTION 345 0.0130
432 PULMONARY OEDEMA 580 0.0129
433 DIARRHOEA HAEMORRHAGIC 121 0.0129
434 RESPIRATION ABNORMAL 89 0.0129
435 MULTIPLE ALLERGIES 101 0.0129
436 GENERALISED TONIC-CLONIC SEIZURE 212 0.0128
437 BLOOD COUNT ABNORMAL 194 0.0128
438 CONCUSSION 99 0.0128
439 PNEUMONIA BACTERIAL 117 0.0127
440 NEPHROPATHY 119 0.0127
441 RESPIRATORY DEPRESSION 156 0.0127
442 PYELONEPHRITIS 110 0.0127
443 DIZZINESS POSTURAL 123 0.0127
444 GRAFT VERSUS HOST DISEASE 91 0.0126
445 ELECTROCARDIOGRAM ABNORMAL 99 0.0126
446 MICTURITION URGENCY 144 0.0126
447 DYSPHONIA 737 0.0126
448 PRODUCT ADHESION ISSUE 450 0.0126
449 HYPERGLYCAEMIA 458 0.0126
450 PALLOR 342 0.0126
451 DRUG INTERACTION 1992 0.0125
452 MUSCLE RIGIDITY 150 0.0125
453 ANGINA PECTORIS 358 0.0125
454 FLUSHING 1270 0.0125
455 EXTRASYSTOLES 87 0.0124
456 HYPOTHERMIA 126 0.0124
457 DERMATITIS BULLOUS 90 0.0124
458 HEPATOTOXICITY 276 0.0124
459 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 93 0.0124
460 BLOOD IRON DECREASED 147 0.0124
461 HYPERTENSION 2623 0.0124
462 INFECTION 1789 0.0123
463 PULMONARY ARTERIAL HYPERTENSION 179 0.0123
464 PRODUCT DOSE OMISSION IN ERROR 349 0.0123
465 INCONTINENCE 130 0.0123
466 THROMBOSIS 988 0.0123
467 COUGH 3441 0.0123
468 ATRIAL FIBRILLATION 1189 0.0122
469 BOWEL MOVEMENT IRREGULARITY 93 0.0121
470 ATAXIA 144 0.0121
471 BLOOD PRESSURE ABNORMAL 241 0.0121
472 FOETAL EXPOSURE DURING PREGNANCY 984 0.0121
473 ILLNESS 1246 0.0121
474 RHINORRHOEA 781 0.0121
475 SINUSITIS 1235 0.0120
476 PLATELET COUNT INCREASED 157 0.0120
477 FUNGAL INFECTION 401 0.0120
478 HEPATIC ENCEPHALOPATHY 112 0.0120
479 DYSPNOEA 6780 0.0120
480 ANURIA 103 0.0120
481 FAECES SOFT 87 0.0120
482 DRUG INTOLERANCE 1155 0.0119
483 BRADYCARDIA 634 0.0119
484 SLEEP APNOEA SYNDROME 228 0.0119
485 SPUTUM DISCOLOURED 113 0.0119
486 DRY MOUTH 966 0.0119
487 HIATUS HERNIA 154 0.0119
488 TOOTH ABSCESS 121 0.0119
489 SPINAL PAIN 139 0.0119
490 URINARY RETENTION 395 0.0118
491 DIVERTICULITIS 328 0.0118
492 HEPATIC FAILURE 356 0.0118
493 PREMATURE BABY 355 0.0118
494 LABORATORY TEST ABNORMAL 348 0.0118
495 PURPURA 104 0.0117
496 PARAESTHESIA ORAL 169 0.0117
497 EAR PAIN 227 0.0117
498 CHEST PAIN 2160 0.0117
499 HAEMATURIA 399 0.0116
500 PNEUMONIA ASPIRATION 290 0.0116
501 LUNG INFECTION 180 0.0116
502 PULMONARY THROMBOSIS 126 0.0115
503 PNEUMOCYSTIS JIROVECII PNEUMONIA 116 0.0115
504 AGEUSIA 288 0.0115
505 MYDRIASIS 148 0.0115
506 HYPERKALAEMIA 404 0.0115
507 ABDOMINAL PAIN LOWER 291 0.0115
508 OEDEMA 624 0.0115
509 JAUNDICE 309 0.0115
510 RIB FRACTURE 235 0.0114
511 HAEMODYNAMIC INSTABILITY 87 0.0114
512 CONFUSIONAL STATE 1845 0.0114
513 BLOOD PRESSURE DECREASED 757 0.0114
514 WHITE BLOOD CELL COUNT INCREASED 437 0.0114
515 FACE OEDEMA 192 0.0114
516 METABOLIC ACIDOSIS 364 0.0114
517 DEEP VEIN THROMBOSIS 738 0.0113
518 POST PROCEDURAL COMPLICATION 218 0.0113
519 BLOOD PRESSURE INCREASED 1734 0.0113
520 VIRAL INFECTION 377 0.0113
521 LOWER RESPIRATORY TRACT INFECTION 514 0.0113
522 PHARYNGITIS STREPTOCOCCAL 122 0.0113
523 PHOTOPHOBIA 212 0.0113
524 MYELODYSPLASTIC SYNDROME 163 0.0113
525 NEOPLASM 129 0.0112
526 NIGHT SWEATS 361 0.0112
527 SHOCK HAEMORRHAGIC 91 0.0112
528 OEDEMA PERIPHERAL 1361 0.0112
529 DIFFUSE LARGE B-CELL LYMPHOMA 86 0.0112
530 LIVE BIRTH 93 0.0111
531 VITAMIN D DECREASED 95 0.0111
532 APHTHOUS ULCER 86 0.0111
533 CHOLELITHIASIS 363 0.0111
534 OROPHARYNGEAL PAIN 1024 0.0111
535 DYSPEPSIA 1088 0.0110
536 KIDNEY INFECTION 217 0.0110
537 SKIN FISSURES 216 0.0110
538 DECREASED ACTIVITY 119 0.0110
539 CHOLESTASIS 211 0.0110
540 PRESYNCOPE 267 0.0110
541 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 573 0.0110
542 NECK PAIN 612 0.0109
543 RESTLESS LEGS SYNDROME 199 0.0109
544 THROAT TIGHTNESS 294 0.0109
545 DYSURIA 400 0.0109
546 NAIL DISORDER 95 0.0108
547 RENAL CYST 86 0.0108
548 RESPIRATORY RATE INCREASED 96 0.0108
549 GALLBLADDER DISORDER 193 0.0108
550 HEART RATE INCREASED 1068 0.0108
551 TENDERNESS 112 0.0107
552 MUSCULAR WEAKNESS 1221 0.0107
553 STAPHYLOCOCCAL INFECTION 354 0.0107
554 PROTEINURIA 204 0.0107
555 SPINAL OSTEOARTHRITIS 94 0.0107
556 UPPER-AIRWAY COUGH SYNDROME 88 0.0107
557 ABDOMINAL PAIN UPPER 2198 0.0107
558 HYPERSOMNIA 306 0.0107
559 INJURY 749 0.0106
560 SYNCOPE 1066 0.0106
561 LETHARGY 612 0.0106
562 SPLENOMEGALY 124 0.0106
563 DENTAL CARIES 117 0.0106
564 CONJUNCTIVITIS 196 0.0106
565 FACIAL PARALYSIS 90 0.0105
566 GASTROINTESTINAL PAIN 116 0.0105
567 PHARYNGEAL SWELLING 103 0.0105
568 THERAPY INTERRUPTED 751 0.0105
569 EMPHYSEMA 106 0.0105
570 POLYURIA 86 0.0105
571 SUDDEN DEATH 111 0.0105
572 ANXIETY 2985 0.0105
573 GASTRIC ULCER 199 0.0105
574 DELIRIUM 363 0.0104
575 MIGRAINE 997 0.0104
576 QUALITY OF LIFE DECREASED 140 0.0104
577 ERYTHEMA 2145 0.0104
578 GINGIVAL PAIN 83 0.0104
579 FEELING HOT 637 0.0104
580 THERAPY PARTIAL RESPONDER 162 0.0104
581 LIVER FUNCTION TEST ABNORMAL 302 0.0104
582 EYE INFECTION 117 0.0104
583 HYPERSENSITIVITY 1920 0.0103
584 GINGIVAL BLEEDING 141 0.0103
585 WOUND INFECTION 113 0.0103
586 LIGAMENT SPRAIN 102 0.0103
587 PRODUCT USE IN UNAPPROVED INDICATION 2554 0.0103
588 PANCREATITIS 543 0.0103
589 ALOPECIA 2016 0.0103
590 DEPRESSED LEVEL OF CONSCIOUSNESS 406 0.0103
591 INFLUENZA 1144 0.0102
592 ACUTE HEPATIC FAILURE 140 0.0102
593 SEIZURE 1183 0.0102
594 TOOTH INFECTION 134 0.0102
595 DYSGEUSIA 754 0.0101
596 SKIN ULCER 262 0.0101
597 APHONIA 141 0.0101
598 FLATULENCE 572 0.0101
599 HYPERTENSIVE CRISIS 112 0.0101
600 OFF LABEL USE 8799 0.0100
601 COLD SWEAT 177 0.0100
602 LIMB INJURY 272 0.0100
603 PERIPHERAL COLDNESS 137 0.0100
604 DEVELOPMENTAL DELAY 90 0.0100
605 IMMUNOSUPPRESSION 88 0.0100
606 BREAST CANCER METASTATIC 107 0.0100
607 INTERVERTEBRAL DISC DEGENERATION 92 0.0099
608 COAGULOPATHY 165 0.0099
609 HEPATIC STEATOSIS 184 0.0099
610 RASH PRURITIC 535 0.0099
611 NEUROLEPTIC MALIGNANT SYNDROME 117 0.0099
612 JOINT INJURY 210 0.0098
613 PERIPHERAL SWELLING 1512 0.0098
614 SLEEP DISORDER 692 0.0098
615 NOCTURIA 119 0.0098
616 GROIN PAIN 86 0.0098
617 RASH 4267 0.0098
618 BLOOD THYROID STIMULATING HORMONE INCREASED 90 0.0098
619 INTENTIONAL DOSE OMISSION 278 0.0097
620 BLOOD POTASSIUM INCREASED 158 0.0097
621 THERAPY NON-RESPONDER 436 0.0097
622 TEMPERATURE INTOLERANCE 100 0.0097
623 HEADACHE 6075 0.0097
624 BRONCHITIS 713 0.0096
625 MUSCLE TWITCHING 222 0.0096
626 ABDOMINAL DISCOMFORT 1614 0.0096
627 HYPOTHYROIDISM 307 0.0096
628 INTENTIONAL PRODUCT MISUSE 838 0.0096
629 BLADDER DISORDER 95 0.0096
630 PAIN 5869 0.0095
631 BODY TEMPERATURE DECREASED 94 0.0095
632 HYPERTHYROIDISM 138 0.0095
633 HEAD INJURY 301 0.0095
634 ORAL DISCOMFORT 132 0.0095
635 BLOOD PRESSURE SYSTOLIC INCREASED 185 0.0095
636 ABSCESS 151 0.0095
637 NASAL CONGESTION 555 0.0094
638 GLOMERULAR FILTRATION RATE DECREASED 116 0.0094
639 PARAESTHESIA 1480 0.0094
640 LYMPHADENOPATHY 332 0.0094
641 MASS 131 0.0094
642 HOT FLUSH 705 0.0093
643 COVID-19 1640 0.0093
644 EMOTIONAL DISTRESS 1129 0.0093
645 FOOT FRACTURE 176 0.0093
646 RESTLESSNESS 339 0.0093
647 PULMONARY CONGESTION 122 0.0092
648 MYOCARDITIS 106 0.0092
649 THROMBOTIC MICROANGIOPATHY 90 0.0092
650 SPINAL FRACTURE 185 0.0092
651 FEELING COLD 257 0.0092
652 PERITONITIS 191 0.0092
653 ASTHMA 1041 0.0092
654 BLOOD PRESSURE FLUCTUATION 221 0.0092
655 RENAL IMPAIRMENT 773 0.0092
656 MUSCLE SPASMS 1684 0.0092
657 CARDIAC FAILURE 733 0.0091
658 HYPERCHOLESTEROLAEMIA 88 0.0091
659 SOMNOLENCE 1827 0.0091
660 LUNG DISORDER 444 0.0091
661 LOSS OF CONSCIOUSNESS 1157 0.0090
662 HAEMORRHAGE INTRACRANIAL 135 0.0090
663 LOCALISED INFECTION 218 0.0090
664 AKATHISIA 123 0.0090
665 THIRST 161 0.0090
666 MULTI-ORGAN FAILURE 155 0.0090
667 FAECES DISCOLOURED 194 0.0089
668 SKIN REACTION 126 0.0089
669 URINARY INCONTINENCE 265 0.0089
670 VERTIGO 543 0.0089
671 TOOTHACHE 161 0.0089
672 INITIAL INSOMNIA 91 0.0089
673 SWELLING 830 0.0089
674 TREMOR 1468 0.0088
675 MALAISE 3873 0.0088
676 ACUTE MYOCARDIAL INFARCTION 260 0.0088
677 SALIVARY HYPERSECRETION 88 0.0088
678 HEPATITIS 225 0.0088
679 TRANSIENT ISCHAEMIC ATTACK 296 0.0088
680 CATARACT 521 0.0087
681 RENAL FAILURE ACUTE 371 0.0087
682 SKIN EXFOLIATION 733 0.0087
683 COMPLICATION ASSOCIATED WITH DEVICE 126 0.0087
684 PALPITATIONS 1016 0.0087
685 CONTUSION 833 0.0086
686 DYSKINESIA 351 0.0086
687 RECTAL HAEMORRHAGE 371 0.0086
688 OBSTRUCTIVE AIRWAYS DISORDER 96 0.0086
689 SPEECH DISORDER 451 0.0086
690 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 146 0.0086
691 PRODUCT USE ISSUE 1612 0.0086
692 BLISTER 481 0.0086
693 FALL 2850 0.0086
694 PRODUCT DOSE OMISSION ISSUE 2513 0.0085
695 SCIATICA 136 0.0085
696 SCAR 146 0.0085
697 SPINAL OPERATION 105 0.0085
698 LACRIMATION INCREASED 257 0.0085
699 DISORIENTATION 337 0.0085
700 ORAL HERPES 166 0.0085
701 HAEMATOCHEZIA 469 0.0085
702 RENAL PAIN 90 0.0085
703 WHEEZING 503 0.0085
704 SHOCK 195 0.0085
705 OSTEOPOROSIS 348 0.0085
706 DEVICE OCCLUSION 119 0.0084
707 DISCOMFORT 514 0.0084
708 SARS-COV-2 TEST POSITIVE 111 0.0084
709 ERUCTATION 162 0.0084
710 RENAL DISORDER 390 0.0084
711 RASH MACULAR 292 0.0083
712 NODULE 109 0.0083
713 COLON CANCER 124 0.0083
714 DIZZINESS 4146 0.0083
715 WOUND 232 0.0083
716 SKIN LESION 226 0.0082
717 JOINT SWELLING 994 0.0082
718 LIVER DISORDER 363 0.0082
719 HEART RATE DECREASED 287 0.0082
720 LIP SWELLING 271 0.0081
721 HOSPITALISATION 1247 0.0081
722 FISTULA 91 0.0081
723 HYPOAESTHESIA 1208 0.0081
724 SWELLING FACE 525 0.0081
725 INTERSTITIAL LUNG DISEASE 390 0.0080
726 RESPIRATORY ARREST 222 0.0080
727 LIMB DISCOMFORT 249 0.0080
728 DIALYSIS 114 0.0080
729 INTENTIONAL PRODUCT USE ISSUE 703 0.0080
730 BLOOD URINE PRESENT 152 0.0080
731 EOSINOPHILIA 140 0.0080
732 TOOTH FRACTURE 88 0.0080
733 DRUG-INDUCED LIVER INJURY 250 0.0080
734 ACCIDENT 95 0.0079
735 PHOTOSENSITIVITY REACTION 131 0.0079
736 SUBDURAL HAEMATOMA 113 0.0079
737 DIPLOPIA 205 0.0079
738 DERMATITIS ALLERGIC 99 0.0079
739 SKIN DISORDER 262 0.0078
740 THERAPY CESSATION 403 0.0078
741 INFLUENZA LIKE ILLNESS 646 0.0078
742 SKIN DISCOLOURATION 360 0.0078
743 NERVE INJURY 87 0.0078
744 RESPIRATORY DISORDER 234 0.0078
745 MYOCARDIAL ISCHAEMIA 89 0.0078
746 ANKLE FRACTURE 121 0.0078
747 NASOPHARYNGITIS 1440 0.0078
748 DRUG LEVEL INCREASED 129 0.0078
749 PROSTATIC SPECIFIC ANTIGEN INCREASED 107 0.0078
750 SURGERY 455 0.0078
751 HAEMATOMA 201 0.0078
752 IRRITABLE BOWEL SYNDROME 166 0.0077
753 THROAT IRRITATION 347 0.0077
754 THYROID DISORDER 119 0.0077
755 GASTROINTESTINAL HAEMORRHAGE 645 0.0077
756 PAIN IN EXTREMITY 2273 0.0077
757 POOR QUALITY SLEEP 166 0.0077
758 CHOLECYSTECTOMY 88 0.0077
759 TOOTH DISORDER 171 0.0077
760 OSTEOMYELITIS 139 0.0077
761 AGITATION 563 0.0077
762 SECRETION DISCHARGE 96 0.0077
763 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 367 0.0076
764 HEAD DISCOMFORT 135 0.0076
765 MUSCULOSKELETAL DISCOMFORT 131 0.0076
766 RASH PAPULAR 170 0.0076
767 ARTHRITIS 595 0.0076
768 GAIT INABILITY 252 0.0075
769 PRODUCT TASTE ABNORMAL 102 0.0075
770 BALANCE DISORDER 651 0.0075
771 INTERVERTEBRAL DISC PROTRUSION 164 0.0075
772 HALLUCINATION 565 0.0075
773 GASTRIC DISORDER 257 0.0075
774 DEPRESSION 1703 0.0075
775 RHEUMATOID ARTHRITIS 849 0.0075
776 HERPES ZOSTER 428 0.0074
777 CHROMATURIA 168 0.0074
778 FREQUENT BOWEL MOVEMENTS 201 0.0074
779 HYPOKINESIA 108 0.0074
780 ARRHYTHMIA 352 0.0074
781 DEATH 6379 0.0074
782 CYTOMEGALOVIRUS INFECTION 123 0.0074
783 HYPOAESTHESIA ORAL 111 0.0074
784 HIP FRACTURE 236 0.0073
785 DRY SKIN 978 0.0073
786 OSTEOARTHRITIS 310 0.0073
787 POST PROCEDURAL HAEMORRHAGE 85 0.0073
788 ALTERED STATE OF CONSCIOUSNESS 158 0.0073
789 MELAENA 160 0.0073
790 POLLAKIURIA 303 0.0073
791 HEART RATE IRREGULAR 164 0.0073
792 PRODUCT USE COMPLAINT 114 0.0072
793 CEREBRAL HAEMORRHAGE 259 0.0072
794 STEVENS-JOHNSON SYNDROME 160 0.0072
795 PARALYSIS 103 0.0072
796 HYPOGLYCAEMIA 349 0.0072
797 HEPATIC CIRRHOSIS 135 0.0072
798 MIDDLE INSOMNIA 134 0.0072
799 MYALGIA 1220 0.0072
800 DIABETIC KETOACIDOSIS 171 0.0071
801 CORONARY ARTERY DISEASE 215 0.0071
802 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1276 0.0071
803 INSOMNIA 1884 0.0071
804 INTERNATIONAL NORMALISED RATIO INCREASED 201 0.0070
805 CONDITION AGGRAVATED 2139 0.0070
806 PRURITUS 2702 0.0070
807 ANGIOEDEMA 311 0.0070
808 MYELOSUPPRESSION 253 0.0070
809 PELVIC PAIN 127 0.0070
810 PULMONARY FIBROSIS 134 0.0070
811 GLOSSODYNIA 156 0.0070
812 MUSCULOSKELETAL PAIN 360 0.0069
813 CARDIOVASCULAR DISORDER 174 0.0068
814 GAIT DISTURBANCE 1305 0.0068
815 DIABETES MELLITUS 519 0.0068
816 DRY EYE 339 0.0068
817 BLOOD CHOLESTEROL INCREASED 315 0.0068
818 BONE DISORDER 123 0.0067
819 CARDIAC FAILURE CONGESTIVE 540 0.0067
820 OBESITY 107 0.0067
821 CARPAL TUNNEL SYNDROME 94 0.0067
822 ARTHRALGIA 2785 0.0067
823 COGNITIVE DISORDER 312 0.0067
824 IMMUNE SYSTEM DISORDER 88 0.0067
825 VISION BLURRED 916 0.0067
826 URTICARIA 1117 0.0067
827 MEMORY IMPAIRMENT 915 0.0067
828 HALLUCINATION, VISUAL 140 0.0066
829 PROCEDURAL PAIN 183 0.0066
830 BACK DISORDER 107 0.0066
831 TOXICITY TO VARIOUS AGENTS 1108 0.0066
832 PERICARDITIS 110 0.0065
833 DERMATITIS 137 0.0065
834 MENTAL DISORDER 283 0.0065
835 EYE SWELLING 241 0.0065
836 EYE PAIN 364 0.0064
837 HERNIA 124 0.0064
838 HEPATIC FUNCTION ABNORMAL 239 0.0064
839 HUNGER 89 0.0064
840 DEPRESSED MOOD 336 0.0063
841 SWOLLEN TONGUE 194 0.0062
842 FIBROMYALGIA 149 0.0061
843 ISCHAEMIC STROKE 109 0.0061
844 PRODUCT PRESCRIBING ISSUE 133 0.0061
845 MUSCULOSKELETAL STIFFNESS 533 0.0061
846 PSORIASIS 792 0.0061
847 BURNING SENSATION 425 0.0061
848 DYSSTASIA 176 0.0060
849 UPPER LIMB FRACTURE 120 0.0060
850 DEAFNESS 157 0.0060
851 IMPAIRED HEALING 196 0.0060
852 MUSCLE TIGHTNESS 96 0.0059
853 RASH GENERALISED 153 0.0059
854 HAEMORRHAGE 615 0.0059
855 PANIC ATTACK 214 0.0059
856 JOINT STIFFNESS 154 0.0059
857 WEIGHT INCREASED 1313 0.0059
858 SENSORY DISTURBANCE 94 0.0059
859 NERVOUS SYSTEM DISORDER 181 0.0058
860 TINNITUS 266 0.0058
861 NEOPLASM MALIGNANT 386 0.0058
862 FEELING ABNORMAL 1381 0.0058
863 MOBILITY DECREASED 414 0.0058
864 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 148 0.0057
865 ADVERSE DRUG REACTION 515 0.0057
866 DELUSION 89 0.0057
867 AMNESIA 372 0.0057
868 PRODUCT PRESCRIBING ERROR 135 0.0057
869 FEELING JITTERY 107 0.0056
870 INFLAMMATION 288 0.0056
871 VISUAL IMPAIRMENT 688 0.0055
872 PSYCHOMOTOR HYPERACTIVITY 92 0.0055
873 RHABDOMYOLYSIS 229 0.0055
874 BLOOD CREATINE PHOSPHOKINASE INCREASED 158 0.0055
875 DRUG ERUPTION 97 0.0055
876 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 300 0.0055
877 CEREBROVASCULAR ACCIDENT 926 0.0055
878 LOWER LIMB FRACTURE 105 0.0055
879 ECZEMA 283 0.0054
880 TREATMENT FAILURE 444 0.0054
881 COMA 255 0.0053
882 PRODUCT AVAILABILITY ISSUE 121 0.0053
883 DRUG PRESCRIBING ERROR 101 0.0053
884 PRODUCT ADMINISTRATION ERROR 106 0.0052
885 ACCIDENTAL OVERDOSE 191 0.0052
886 TOOTH LOSS 108 0.0052
887 CHOKING 101 0.0052
888 BONE DENSITY DECREASED 162 0.0052
889 LIVER INJURY 126 0.0051
890 EMOTIONAL DISORDER 157 0.0051
891 ILL-DEFINED DISORDER 309 0.0051
892 MOVEMENT DISORDER 163 0.0051
893 EPILEPSY 152 0.0050
894 INCREASED APPETITE 95 0.0050
895 ROAD TRAFFIC ACCIDENT 207 0.0049
896 HYPOACUSIS 213 0.0049
897 CARDIAC DISORDER 461 0.0049
898 PRODUCT DOSE OMISSION 321 0.0049
899 BLOOD GLUCOSE DECREASED 236 0.0049
900 DISTURBANCE IN ATTENTION 263 0.0049
901 PAIN OF SKIN 129 0.0048
902 IMPAIRED WORK ABILITY 102 0.0048
903 PRESCRIBED UNDERDOSE 95 0.0048
904 UNEVALUABLE EVENT 358 0.0047
905 DISABILITY 93 0.0047
906 EYE PRURITUS 157 0.0047
907 MUSCULOSKELETAL DISORDER 87 0.0046
908 COMPLETED SUICIDE 379 0.0045
909 LACTIC ACIDOSIS 147 0.0045
910 MENTAL IMPAIRMENT 109 0.0045
911 PANCREATIC CARCINOMA 129 0.0045
912 TREATMENT NONCOMPLIANCE 244 0.0045
913 SKIN CANCER 96 0.0045
914 NERVOUSNESS 232 0.0044
915 EXTRAPYRAMIDAL DISORDER 110 0.0044
916 CONVULSION 251 0.0044
917 VAGINAL HAEMORRHAGE 190 0.0044
918 CEREBRAL INFARCTION 104 0.0043
919 OVERDOSE 914 0.0042
920 OCULAR HYPERAEMIA 200 0.0042
921 PSORIATIC ARTHROPATHY 170 0.0042
922 COLITIS ULCERATIVE 187 0.0042
923 OSTEONECROSIS OF JAW 103 0.0042
924 ABNORMAL BEHAVIOUR 159 0.0040
925 IRRITABILITY 239 0.0040
926 ARTHROPATHY 218 0.0039
927 UNDERDOSE 284 0.0039
928 THERAPEUTIC PRODUCT EFFECT DECREASED 174 0.0039
929 SUICIDAL IDEATION 354 0.0039
930 EYE DISORDER 127 0.0039
931 PSYCHOTIC DISORDER 114 0.0039
932 CRYING 140 0.0038
933 FEMUR FRACTURE 119 0.0038
934 BLINDNESS 156 0.0038
935 DRUG INEFFECTIVE 5024 0.0038
936 OSTEONECROSIS 125 0.0038
937 LUNG NEOPLASM MALIGNANT 156 0.0038
938 DERMATITIS ATOPIC 198 0.0038
939 THERAPEUTIC RESPONSE UNEXPECTED 167 0.0037
940 MOOD ALTERED 100 0.0037
941 THERAPEUTIC RESPONSE SHORTENED 121 0.0036
942 ADVERSE EVENT 334 0.0036
943 DEVICE DISLOCATION 154 0.0035
944 FEAR 95 0.0035
945 SYSTEMIC LUPUS ERYTHEMATOSUS 125 0.0035
946 BLOOD GLUCOSE INCREASED 659 0.0035
947 EYE IRRITATION 200 0.0035
948 DEMENTIA 95 0.0034
949 GASTRIC CANCER 86 0.0034
950 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 241 0.0034
951 INTENTIONAL OVERDOSE 212 0.0033
952 APPLICATION SITE ERYTHEMA 86 0.0033
953 MEDICATION ERROR 182 0.0033
954 SUICIDE ATTEMPT 196 0.0032
955 NEEDLE ISSUE 93 0.0032
956 TYPE 2 DIABETES MELLITUS 107 0.0032
957 ACNE 239 0.0031
958 MYOCARDIAL INFARCTION 531 0.0030
959 SKIN IRRITATION 139 0.0030
960 MOOD SWINGS 96 0.0030
961 MULTIPLE SCLEROSIS RELAPSE 206 0.0030
962 INJECTION SITE RASH 92 0.0030
963 THERAPEUTIC RESPONSE DECREASED 178 0.0029
964 AGGRESSION 146 0.0029
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 589 0.0029
966 DISEASE RECURRENCE 138 0.0029
967 WITHDRAWAL SYNDROME 120 0.0029
968 INJECTION SITE MASS 103 0.0028
969 INJECTION SITE REACTION 188 0.0027
970 ANGER 92 0.0027
971 INCORRECT DOSE ADMINISTERED 619 0.0027
972 INJECTION SITE BRUISING 215 0.0027
973 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 189 0.0027
974 INJECTION SITE ERYTHEMA 305 0.0025
975 MULTIPLE SCLEROSIS 116 0.0024
976 DRUG EFFECT INCOMPLETE 88 0.0024
977 INJECTION SITE PRURITUS 162 0.0024
978 DEVICE ISSUE 213 0.0024
979 INJECTION SITE PAIN 716 0.0023
980 EXTRA DOSE ADMINISTERED 94 0.0023
981 DRUG DOSE OMISSION 383 0.0023
982 NO ADVERSE EVENT 418 0.0023
983 DEVICE LEAKAGE 97 0.0022
984 DRUG WITHDRAWAL SYNDROME 188 0.0021
985 INJECTION SITE SWELLING 164 0.0021
986 BREAST CANCER 198 0.0021
987 ABORTION SPONTANEOUS 83 0.0021
988 SKIN BURNING SENSATION 143 0.0020
989 PRODUCT QUALITY ISSUE 258 0.0019
990 DEVICE MALFUNCTION 127 0.0018
991 INJECTION SITE HAEMORRHAGE 142 0.0018
992 PRODUCT STORAGE ERROR 134 0.0015
993 DRUG ABUSE 121 0.0015
994 ACCIDENTAL EXPOSURE TO PRODUCT 137 0.0013
995 DRUG DEPENDENCE 167 0.0010